Amantadine for Improving Alertness in ICU Patients

We are studying whether Amantadine can enhance responsiveness in patients receiving intensive care. The trial will measure changes in alertness over several days using established clinical scoring systems.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Amantadin Ratiopharm
Amantadin Ratiopharm is a medicine used to help control symptoms of Parkinson’s disease and certain movement disorders.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Amantadine Hemisulfate
Amantadine hemisulfate is a substance that helps improve movement symptoms in Parkinson's disease and reduce certain treatment-related movement side effects.
Amantadine Hydrochloride
Amantadine hydrochloride is a substance that helps improve movement in Parkinson's disease and treats certain influenza A infections.

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Amantadin 1 A Pharma
Amantadin Hexal
Amantadin Neuraxpharm

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Universitaetsklinikum Tuebingen AöR
Department forneurology and stroke
Tübingen, Germany
Sponsor: Universitaetsklinikum Tuebingen AöR
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.